Exploring multidimensional factors of herpes zoster risk in rheumatoid arthritis patients undergoing JAK inhibitor treatment

被引：0
|
作者：
Zhou, Lianwei [1 ]
Xing, Yuhe [1 ]
Li, Wenbo [1 ,2 ]
机构：
[1] Jiamusi Univ, Sch Clin Med, Jiamusi, Peoples R China
[2] Jiamusi Univ, Jiamusi, Heilongjiang, Peoples R China
来源：
CLINICAL RHEUMATOLOGY | 2024年 / 43卷 / 09期
关键词：
D O I：
10.1007/s10067-024-07076-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：3033 / 3034
页数：2
相关论文
共 50 条
  • [21] Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis
    Winthrop, Kevin L.
    Yamanaka, Hisashi
    Valdez, Hernan
    Mortensen, Eric
    Chew, Robert
    Krishnaswami, Sriram
    Kawabata, Thomas
    Riese, Richard
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (10) : 2675 - 2684
  • [22] Psoriatic arthritis treatment and the risk of herpes zoster
    Zisman, D.
    Bitterman, H.
    Shalom, G.
    Feldhamer, I.
    Comanesther, D.
    Batat, E.
    Greenberg-Dotan, S.
    Cohen, S.
    Cohen, A. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (01) : 131 - 135
  • [23] Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment
    Winthrop, Kevin L.
    Curtis, Jeffrey R.
    Yamaoka, Kunihiro
    Lee, Eun Bong
    Hirose, Tomohiro
    Rivas, Jose L.
    Kwok, Kenneth
    Burmester, Gerd R.
    RHEUMATOLOGY AND THERAPY, 2022, 9 (01) : 243 - 263
  • [24] Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment
    Kevin L. Winthrop
    Jeffrey R. Curtis
    Kunihiro Yamaoka
    Eun Bong Lee
    Tomohiro Hirose
    Jose L. Rivas
    Kenneth Kwok
    Gerd R. Burmester
    Rheumatology and Therapy, 2022, 9 : 243 - 263
  • [25] Herpes zoster risk in DMARD-treated rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2021, 3 (09): : E618 - E618
  • [26] Herpes zoster infection risk in patients with rheumatoid arthritis on tumour necrosis factor inhibitors
    Ranganathan, Prabha
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (05) : E4 - E4
  • [27] RISK OF HERPES ZOSTER IN PATIENTS WITH RHEUMATOID ARTHRITIS UNDER BIOLOGICAL, TARGETED SYNTHETIC, AND CONVENTIONAL SYNTHETIC DMARD TREATMENT
    Strangfeld, A.
    Redeker, I.
    Kekow, J.
    Burmester, G. R.
    Braun, J.
    Zink, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 150 - 151
  • [28] RISK OF HERPES ZOSTER IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THE BIOLOGICS ERA BASED ON THE IORRA COHORT
    Yamaguchi, R.
    Nakajima, A.
    Inoue, E.
    Ochiai, M.
    Shimizu, Y.
    Sugimoto, N.
    Tanaka, E.
    Ikari, K.
    Taniguchi, A.
    Yamanaka, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 263 - 264
  • [29] Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti-TNF-α Agents
    Strangfeld, Anja
    Listing, Joachim
    Herzer, Peter
    Liebhaber, Anke
    Rockwitz, Karin
    Richter, Constanze
    Zink, Angela
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (07): : 737 - 744
  • [30] The Incidence of Herpes Zoster Is Increased in the Population of Patients With Rheumatoid Arthritis
    Zhuo, Ning
    Wang, Gang
    Wu, Gang
    JOURNAL OF RHEUMATOLOGY, 2024, 51 (03) : 323 - 323
12345